International Edition
Latest News
Health

Colorectal Cancer Risk Assessment Tool Launched by Fred Hutch

MyGeneRisk: New Tool Estimates Colorectal Cancer RiskTable of ContentsMyGeneRisk: New Tool Estimates Colorectal Cancer RiskUnderstanding Colorectal Cancer Riskwhy is Colorectal Cancer Risk Assessment Crucial?How Does MyGeneRisk Work?The Role of Genetics in Colorectal CancerBenefits of Using MyGeneRiskKey Takeaways 2025/12/19…

Colorectal Cancer Risk Assessment Tool Launched by Fred Hutch

MyGeneRisk: New Tool Estimates Colorectal Cancer Risk

Table of Contents

2025/12/19 03:07:05

Understanding Colorectal Cancer Risk

Fred Hutch Cancer Center researchers have developed MyGeneRisk, a free, online tool that allows individuals to quickly assess their risk of developing colorectal cancer. The calculator uses personal health information, lifestyle factors, and genetic data to provide a personalized risk estimate.

why is Colorectal Cancer Risk Assessment Crucial?

Colorectal cancer is becoming increasingly common. It is indeed currently the third most common cancer diagnosed in the United States and the second leading cause of cancer death. Early identification of risk factors and proactive screening are crucial for prevention and improved outcomes.

How Does MyGeneRisk Work?

MyGeneRisk is designed to be user-friendly. Users input information regarding:

  • Lifestyle Factors: diet, exercise habits, and smoking status.
  • Personal Health History: Family history of colorectal cancer or polyps, personal history of inflammatory bowel disease, and previous screening results.
  • Genetic Data (Optional): Users can upload genetic data from companies like 23andMe or AncestryDNA to refine their risk assessment. The tool analyzes common genetic variants associated wiht colorectal cancer risk.

The tool then generates a personalized risk estimate, helping individuals understand their likelihood of developing the disease.

The Role of Genetics in Colorectal Cancer

While lifestyle and environmental factors play a significant role, genetics can also influence colorectal cancer risk. Certain genetic mutations, like those in the APC, KRAS, or MLH1 genes, can substantially increase a person’s risk. MyGeneRisk analyzes common genetic variants, providing a more extensive risk assessment than relying on family history alone.

Benefits of Using MyGeneRisk

  • Personalized Risk Assessment: Provides a tailored estimate based on individual factors.
  • Early Detection: Helps individuals understand when to begin screening or discuss risk-reducing strategies with their doctor.
  • Empowerment: Provides individuals with information to make informed decisions about their health.
  • Accessibility: The tool is free and available online to anyone with internet access.

Key Takeaways

  • Colorectal cancer incidence is rising in the U.S.
  • MyGeneRisk is a free online tool for assessing individual risk.
  • The tool considers lifestyle, health history, and optional genetic data.
  • Early risk assessment can lead to proactive screening and improved outcomes.

The growth of MyGeneRisk represents a significant step forward in personalized cancer prevention. By empowering individuals with knowledge about their risk, researchers hope to encourage earlier detection and ultimately reduce the burden of colorectal cancer. Continued research and refinement of risk prediction models will be essential to further improve the accuracy and effectiveness of tools like MyGeneRisk.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”